Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine

Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine

Drug Office - Pharmaceutical Trade Homepage

药物办公室- 消费者主页

Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome as Syndromes of Cerebrovascular Dysregulation

Drug-Induced Disorders of the Nervous System

Panadol CF

藥物辦公室- 消費者主頁

Pseudoephedrine safety review due to rare brain risk

Other safety alerts - 2024-03-18 (1)

PDF) Pseudoephedrine—Benefits and Risks

Posterior Reversible Encephalopathy Syndrome (PRES): Holohemispheric Watershed Pattern

Triprolidine + Pseudoephedrine: Indication, Dosage, Side Effect, Precaution

Cerebrovascular Dysregulation: Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.